Lactobacillus mucoase for relieving endotoxin infection and application

A technology of Lactobacillus mucosae and endotoxin, applied in the field of microorganisms, can solve the problems of insignificant curative effect, inability to effectively remove endotoxin, insufficient clinical data, etc., and achieve the effect of increasing the content of short-chain fatty acids

A technology of Lactobacillus mucosae and endotoxin, applied in the field of microorganisms, can solve the problems of insignificant curative effect, inability to effectively remove endotoxin, insufficient clinical data, etc., and achieve the effect of increasing the content of short-chain fatty acids

CN112625968AActive Publication Date: 2021-04-09JIANGNAN UNIV

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lactobacillus mucoase for relieving endotoxin infection and application
  • Lactobacillus mucoase for relieving endotoxin infection and application
  • Lactobacillus mucoase for relieving endotoxin infection and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1: Screening, identification, cultivation and preservation of mucosal lactobacillus CCFM1142

[0049] 1. Screening

[0050]Take 1g of healthy human feces samples from Mayang Miao Autonomous County, Huaihua City, Hunan Province, apply them on MRS solid medium after gradient dilution, and culture them in an anaerobic environment at 37°C for 72 hours, observe and record the colony morphology; , Protruding, white and yellowish colonies were streaked on the MRS solid medium, and purified and cultivated under anaerobic conditions at 37°C. Repeat this operation 3 times to obtain purified single colonies; pick a single colony on Stretch on the MRS solid medium, culture anaerobically at 37°C for 36 hours, perform Gram staining on the obtained colonies, record the morphology of the colonies, and investigate the physiological and biochemical characteristics of the strains according to the "Common Bacterial System Identification Manual", and retain Gram-negative , the colo...

Embodiment 2

[0065] Embodiment 2: Preparation of Lactobacillus mucous membrane CCFM1142 bacterium liquid

[0066] (1) Dip the bacterial solution of Lactobacillus mucous membranes CCFM1142 from the glycerol tube, streak it on the MRS solid medium, and culture it at 37°C for 48 hours under anaerobic environment to obtain a single colony; pick a single colony and inoculate it in the MRS liquid medium, In an anaerobic environment, culture at 37° C. for 48 hours for activation culture, and repeat this operation 3 times to obtain the activated bacterial liquid.

[0067] (2) Inoculate the activated bacterial liquid obtained in step (1) into the MRS liquid medium according to the inoculum size of 2% (v / v), cultivate at 37°C for 24 hours to obtain a fermentation liquid, and collect the bacteria by centrifugation of the fermentation liquid body, resuspend the cell body with physiological saline, and adjust the number of viable cells to 5×10 9 CFU / mL, made into bacterial suspension.

Embodiment 3

[0068] Example 3: Effect of Lactobacillus CCFM1142 on LPS Infection of LPS in Mouse Serum LPS

[0069] Fifty-six 6-week-old, 18-20g C57BL / 6J male mice were randomly divided into 4 groups after a one-week adaptation period: control group, LPS model group, CCFM1142 group and FZJTZ26M3 group, with 8 mice in each group. Among them, the control group was intraperitoneally injected with 0.2mL of normal saline and gavaged with 0.2mL of protective agent every day (the preparation method of the protective agent was: 130g / L skim milk was sterilized at 105°C for 10min; 20g / L of sucrose solution was mixed with 20g / L trehalose solution was autoclaved at 115°C for 20 minutes; the three solutions were mixed at a volume ratio of 1:1:1 to be the protective agent); the LPS modeling group was intraperitoneally injected with 0.2 mL of LPS solution (LPS dissolved in LPS solution with a final concentration of 0.15 mg / kg was made from normal saline) and 0.2 mL of protective agent was administered i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a lactobacillus mucoase for relieving endotoxin infection and application, and belongs to the technical field of microorganisms. The lactobacillus mucoase CCFM1142 capable of relieving endotoxin infection is obtained by screening through a large number of experiments, and the strain can reduce the content of proinflammatory factors in host blood infected by endotoxin, increase the concentration of anti-inflammatory factors and stabilize intestinal flora composition. By further investigating the application of the strain in food and drug combinations, experiments show that the food or drug containing the lactobacillus mucoase CCFM1142 can be used for preparing foods or drugs for preventing and / or treating endotoxin infection, and has a wide application prospect.

Description

technical field [0001] The invention relates to a strain of mucosal lactobacillus for alleviating endotoxin infection and its application, belonging to the technical field of microbes. Background technique [0002] Endotoxin, also known as lipopolysaccharide, is an important component of the cell wall of Gram-negative bacteria. Endotoxin has a stable structure and is mainly composed of three parts: polysaccharide antigen, core polysaccharide and lipid A (lipid A). Lipid A is a lipidated glucosamine disaccharide that is pyrogenic and the major toxic component of Gram-negative bacterial endotoxins. Under normal circumstances, endotoxins are only released when the bacteria die and dissolve or the bacterial cells are destroyed by artificial methods, and the structure of endotoxins is stable. biological activity. [0003] The intestinal lumen of a normal body contains a large number of intestinal bacteria, and the intestinal mucosa can selectively absorb nutrients and prevent ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
09 Apr 2021
Publication
CN112625968A
IPC
C12N1/20; A61K35/747; A61P39/02; A61P31/04; A61P1/12; A23C9/123; A23L11/65; A23L11/50; A23L2/38; A23L2/84; C12R1/225
CPC
C12N1/20; A61K35/747; A61P39/02; A61P31/04; A61P1/12; A23C9/1234; A23C11/106; A23L2/382
Inventors
杨波; 陈卫